- Home >
- Clinicals Trials >
- ALCINA-4 (IC 2020-11)
Breast cancer
ALCINA-4 (IC 2020-11)
Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4
- Open at Paris since : 23/09/2022
- Open at Saint-Cloud since : 18/05/2022
- Target : Adult
- Phase : Clinical trial
Trial description
Multi-cohort exploratory prospective study. Participation in the ALCINA 4 study does not change the standard management of the patient, including the treatments administered. A sampling schedule will be set up for each cohort.;Depending on the clinical context studied and the biomarkers studied and/or sought, the timing of blood samples will vary between cohorts. There may be up to 4 samples taken per patient for up to 12 or 18 months. If a specific tumor sample is required, it will be collected only once during the Study.
Url of the trial